InnovAge (NASDAQ: INNV) net income
InnovAge reported a net loss of $2.5m for fiscal 2026; in fiscal 2025 it reported a net loss of $30.3m. Earnings per share were −$0.02.
InnovAge's best year of the last 7 was fiscal 2020. It reported a loss in 6 of those 7 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2026 | −$2.5m | — | −0.3% | −$0.02 |
| 2025 | −$30.3m | — | −3.6% | −$0.22 |
| 2024 | −$21.3m | — | −2.8% | −$0.16 |
| 2023 | −$40.7m | — | −5.9% | −$0.30 |
| 2022 | −$6.5m | — | −0.9% | −$0.05 |
| 2021 | −$44.0m | −267.4% | −6.9% | −$0.36 |
| 2020 | $26.3m | — | 4.6% | $0.20 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
InnovAge net income compared with its sector
By net income for its latest fiscal year, InnovAge ranks 176th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of InnovAge, −0.3%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 174th | Certara | −$1.6m | −0.4% |
| 175th | Arrowhead Pharmaceuticals | −$1.6m | −0.2% |
| 176th | InnovAge | −$2.5m | −0.3% |
| 177th | Koru Medical Systems | −$2.6m | −6.4% |
| 178th | Agenus | −$3.1m | −2.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of InnovAge
- How much did InnovAge earn in fiscal 2026?
- InnovAge reported a net loss of $2.5m for fiscal 2026. In fiscal 2025 it reported a net loss of $30.3m.
- What are the earnings per share of InnovAge?
- They were −$0.02 in fiscal 2026, compared with −$0.22 in fiscal 2025.
- What was the most profitable year for InnovAge?
- Of its last 7 fiscal years, fiscal 2020, with $26.3m.
- Where does InnovAge rank in its sector by net income?
- It ranks 176th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for InnovAge come from?
- From the annual report (Form 10-K) that InnovAge files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that InnovAge files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on InnovAge: the InnovAge page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.